DFX Intelligence

Data Factory

Ascendispharma

We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, caregivers & HCPs.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:44c96d3a-5429-468c-b757-6964f04d0cb4

Data as of Sep 18, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 12:25 PM UTC and rebuilt at most every 15 minutes.

Relationships: 4
Dated events: 1
On other graphs: 1
Observed: Sep 12, 2026 to Sep 18, 2026
8 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Private Equityidentity

Ascendispharma

Portfolio company · cited

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Rounds: 0
Investors: 3
People: 0
Website: ascendispharma.com

Investors

Investor	Class	Fund	Partner	Role	Attribution
Vivo Capital, LLC	Multi stage VC	n/a	n/a	lead	Unknown
Avoro Capital Advisors LLC	Institutional VC	n/a	n/a	unknown	Unknown
Vivo Capital, LLC	Multi stage VC	n/a	n/a	unknown	Unknown
Sofinnova Investments, Inc.	Institutional VC	n/a	n/a	unknown	Unknown

Relationships

Invested in (3)

← Vivo Capital, LLCFirmPortfolio listing
Sep 18, 2026 to presentfactThe subject's own site
← Avoro Capital Advisors LLCFirmPortfolio listing
Sep 16, 2026 to presentfactThe subject's own site
← Sofinnova Investments, Inc.FirmPortfolio listing
Sep 12, 2026 to presentfactThe subject's own site

Dated events

1 bookkeeping events (roster, classification and holdings changes) folded below

Show 1 bookkeeping events

First seen by DFX
Sep 16, 2026
date not stated
Ascendispharma no longer listed on Sofinnova Investments, Inc.'s portfolio page

Provenance

Graph: Venture Capital
Canonical id: dfx:vc:44c96d3a-5429-468c-b757-6964f04d0cb4
First observed: Sep 12, 2026
Last observed: Sep 18, 2026 44 h ago
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Ascendispharma

We apply our TransCon technology platform to build a leading, fully integrated biopharma company & make a meaningful difference for patients, caregivers & HCPs.

This is the graph view. The full profile, with its team, deals and sources, is on Venture Capital.Open the full profile →

Search this name across graphsid dfx:vc:44c96d3a-5429-468c-b757-6964f04d0cb4

Data as of Sep 18, 2026 (this record's last observation) from Sworn filings; Announcements; Limited partners. Page built Sep 20, 2026, 12:25 PM UTC and rebuilt at most every 15 minutes.

Investor

Class

Fund

Partner

Role

Attribution

Vivo Capital, LLC

Multi stage VC

n/a

lead

Unknown

Avoro Capital Advisors LLC

Institutional VC

n/a

unknown

Unknown

Vivo Capital, LLC

Multi stage VC

n/a

unknown

Unknown

Sofinnova Investments, Inc.

Institutional VC

n/a

unknown

Unknown